199 related articles for article (PubMed ID: 34834355)
1. Ceragenin-Coated Non-Spherical Gold Nanoparticles as Novel Candidacidal Agents.
Skłodowski K; Chmielewska SJ; Depciuch J; Deptuła P; Piktel E; Daniluk T; Zakrzewska M; Czarnowski M; Cieśluk M; Durnaś B; Parlińska-Wojtan M; Savage PB; Bucki R
Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834355
[TBL] [Abstract][Full Text] [Related]
2. Bactericidal Properties of Rod-, Peanut-, and Star-Shaped Gold Nanoparticles Coated with Ceragenin CSA-131 against Multidrug-Resistant Bacterial Strains.
Chmielewska SJ; Skłodowski K; Depciuch J; Deptuła P; Piktel E; Fiedoruk K; Kot P; Paprocka P; Fortunka K; Wollny T; Wolak P; Parlinska-Wojtan M; Savage PB; Bucki R
Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33809901
[TBL] [Abstract][Full Text] [Related]
3. Rod-shaped gold nanoparticles exert potent candidacidal activity and decrease the adhesion of fungal cells.
Piktel E; Suprewicz Ł; Depciuch J; Cieśluk M; Chmielewska S; Durnaś B; Król G; Wollny T; Deptuła P; Kochanowicz J; Kułakowska A; Fiedoruk K; Maximenko A; Parlińska-Wojtan M; Bucki R
Nanomedicine (Lond); 2020 Dec; 15(28):2733-2752. PubMed ID: 33090058
[No Abstract] [Full Text] [Related]
4. Peanut-Shaped Gold Nanoparticles with Shells of Ceragenin CSA-131 Display the Ability to Inhibit Ovarian Cancer Growth In Vitro and in a Tumor Xenograft Model.
Piktel E; Oscilowska I; Suprewicz Ł; Depciuch J; Marcińczyk N; Chabielska E; Wolak P; Głuszek K; Klimek J; Zieliński PM; Marzec MT; Savage PB; Parlińska-Wojtan M; Bucki R
Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771587
[TBL] [Abstract][Full Text] [Related]
5. Formulation and candidacidal activity of magnetic nanoparticles coated with cathelicidin LL-37 and ceragenin CSA-13.
Niemirowicz K; Durnaś B; Tokajuk G; Piktel E; Michalak G; Gu X; Kułakowska A; Savage PB; Bucki R
Sci Rep; 2017 Jul; 7(1):4610. PubMed ID: 28676673
[TBL] [Abstract][Full Text] [Related]
6. Assessment of Ceragenins in Prevention of Damage to Voice Prostheses Caused by
Spałek J; Daniluk T; Godlewski A; Deptuła P; Wnorowska U; Ziembicka D; Cieśluk M; Fiedoruk K; Ciborowski M; Krętowski A; Góźdź S; Durnaś B; Savage PB; Okła S; Bucki R
Pathogens; 2021 Oct; 10(11):. PubMed ID: 34832527
[TBL] [Abstract][Full Text] [Related]
7. Quantification of Synergistic Effects of Ceragenin CSA-131 Combined with Iron Oxide Magnetic Nanoparticles Against Cancer Cells.
Piktel E; Markiewicz KH; Wilczewska AZ; Daniluk T; Chmielewska S; Niemirowicz-Laskowska K; Mystkowska J; Paprocka P; Savage PB; Bucki R
Int J Nanomedicine; 2020; 15():4573-4589. PubMed ID: 32606693
[TBL] [Abstract][Full Text] [Related]
8. Ceragenins are active against drug-resistant Candida auris clinical isolates in planktonic and biofilm forms.
Hashemi MM; Rovig J; Holden BS; Taylor MF; Weber S; Wilson J; Hilton B; Zaugg AL; Ellis SW; Yost CD; Finnegan PM; Kistler CK; Berkow EL; Deng S; Lockhart SR; Peterson M; Savage PB
J Antimicrob Chemother; 2018 Jun; 73(6):1537-1545. PubMed ID: 29635279
[TBL] [Abstract][Full Text] [Related]
9. Targeting bacteria causing otitis media using nanosystems containing nonspherical gold nanoparticles and ceragenins.
Prasad SV; Piktel E; Depciuch J; Maximenko A; Suprewicz Ł; Daniluk T; Spałek J; Wnorowska U; M Zielinski P; Parlinska-Wojtan M; B Savage P; Okła S; Fiedoruk K; Bucki R
Nanomedicine (Lond); 2021 Dec; 16(30):2657-2678. PubMed ID: 34823374
[TBL] [Abstract][Full Text] [Related]
10. Comparative in vitro antimicrobial activities of CSA-142 and CSA-192, second-generation ceragenins, with CSA-13 against various microorganisms.
Bozkurt Guzel C; Oyardi O; B Savage P
J Chemother; 2018; 30(6-8):332-337. PubMed ID: 30663553
[TBL] [Abstract][Full Text] [Related]
11. Investigation of the in vitro antifungal and antibiofilm activities of ceragenins CSA-8, CSA-13, CSA-44, CSA-131, and CSA-138 against Candida species.
Bozkurt-Guzel C; Hacioglu M; Savage PB
Diagn Microbiol Infect Dis; 2018 Aug; 91(4):324-330. PubMed ID: 29680320
[TBL] [Abstract][Full Text] [Related]
12. Comparison of antifungal and cytotoxicity activities of titanium dioxide and zinc oxide nanoparticles with amphotericin B against different Candida species: In vitro evaluation.
Ahmadpour Kermani S; Salari S; Ghasemi Nejad Almani P
J Clin Lab Anal; 2021 Jan; 35(1):e23577. PubMed ID: 32920952
[TBL] [Abstract][Full Text] [Related]
13. Ceragenins and Ceragenin-Based Core-Shell Nanosystems as New Antibacterial Agents against Gram-Negative Rods Causing Nosocomial Infections.
Karasiński M; Wnorowska U; Durnaś B; Król G; Daniluk T; Skłodowski K; Głuszek K; Piktel E; Okła S; Bucki R
Pathogens; 2023 Nov; 12(11):. PubMed ID: 38003809
[TBL] [Abstract][Full Text] [Related]
14. Antifungal susceptibilities, in vitro production of virulence factors and activities of ceragenins against Candida spp. isolated from vulvovaginal candidiasis.
Hacioglu M; Guzel CB; Savage PB; Tan ASB
Med Mycol; 2019 Apr; 57(3):291-299. PubMed ID: 29846682
[TBL] [Abstract][Full Text] [Related]
15. In vitro assessment of CSA-131 and CSA-131 poloxamer form for the treatment of Stenotrophomonas maltophilia infections in cystic fibrosis.
Oyardi Ö; Savage PB; Erturan Z; Bozkurt-Guzel C
J Antimicrob Chemother; 2021 Jan; 76(2):443-450. PubMed ID: 33094334
[TBL] [Abstract][Full Text] [Related]
16. Ceragenin CSA-13 as free molecules and attached to magnetic nanoparticle surfaces induce caspase-dependent apoptosis in human breast cancer cells via disruption of cell oxidative balance.
Piktel E; Prokop I; Wnorowska U; Król G; Cieśluk M; Niemirowicz K; Savage PB; Bucki R
Oncotarget; 2018 Apr; 9(31):21904-21920. PubMed ID: 29774111
[TBL] [Abstract][Full Text] [Related]
17. Bactericidal activity and biocompatibility of ceragenin-coated magnetic nanoparticles.
Niemirowicz K; Surel U; Wilczewska AZ; Mystkowska J; Piktel E; Gu X; Namiot Z; Kułakowska A; Savage PB; Bucki R
J Nanobiotechnology; 2015 May; 13():32. PubMed ID: 25929281
[TBL] [Abstract][Full Text] [Related]
18. In vitro evaluation of the potential for resistance development to ceragenin CSA-13.
Pollard JE; Snarr J; Chaudhary V; Jennings JD; Shaw H; Christiansen B; Wright J; Jia W; Bishop RE; Savage PB
J Antimicrob Chemother; 2012 Nov; 67(11):2665-72. PubMed ID: 22899801
[TBL] [Abstract][Full Text] [Related]
19. CSA-131, a ceragenin active against colistin-resistant Acinetobacter baumannii and Pseudomonas aeruginosa clinical isolates.
Vila-Farrés X; Callarisa AE; Gu X; Savage PB; Giralt E; Vila J
Int J Antimicrob Agents; 2015 Nov; 46(5):568-71. PubMed ID: 26395218
[TBL] [Abstract][Full Text] [Related]
20. Release of calcium from intracellular stores and subsequent uptake by mitochondria are essential for the candidacidal activity of an N-terminal peptide of human lactoferrin.
Lupetti A; Brouwer CP; Dogterom-Ballering HE; Senesi S; Campa M; Van Dissel JT; Nibbering PH
J Antimicrob Chemother; 2004 Sep; 54(3):603-8. PubMed ID: 15282237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
